我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
11
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
5
45.5%
招募中
1
9.1%
终止
Unknown
4
36.4%
暂无批准数据
- A cross-sectional study of 772 pediatric and adolescent patients with moderate-to-severe atopic dermatitis revealed distinct age-related differences in disease burden and treatment patterns. - Adolescent patients (12-17 years) experienced significantly higher psychological distress, including anxiety, embarrassment, and social impacts, compared to younger children (0-11 years). - Pediatric patients were more likely to report sleep disruption as their most bothersome symptom, while adolescents faced greater emotional burden related to the visual aspects of their condition. - The findings highlight the need for age-specific treatment strategies and improved therapeutic options for both age groups in the evolving atopic dermatitis treatment landscape.